Colorectal Cancer Therapeutics Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2019 – 2028

“The global colorectal cancer therapeutics market was valued at US$ 10.73 Billion in 2020 and is projected to reach US$ 19.89 Billion by 2028; registering a CAGR of 8.1% during the forecast period 2021- 2028”, Says Accurize Market Research.
The rising incidence of life-threatening diseases worldwide and awareness among individuals about the treatment concerning the treatment of colorectal cancer are expected to fuel the global colorectal cancer therapeutics market. Numerous reasons leading to the growth of colorectal cancer include obesity, smoking and drinking habits, and intake of improper nutrients. Symptoms owing to colorectal cancer consist of constipation or diarrhea, weakness, fatigue, red blood stool, weight loss, pain in the abdomen, bowel movements, and bloating in the abdomen region. However, an increase in research and development for the new products for the treatment of colorectal cancer and their launches in the market is expected for the growth of the global colorectal cancer therapeutics market in the forecast period. Presently numerous therapeutics have been launched and show a positive result rate. A report published by WHO states that 70% hike in colorectal cancer is predicted by 2030.
Further, higher cases of casualties or mortality rates and increasing awareness for the effective treatment of colorectal cancer via therapeutics are projected to garner a positive response for the growth of the global colorectal therapeutics market growth in the upcoming years. Additionally, the existence of prominent players and the need for cheaper generics for chemotherapy is further anticipated in the comprehensive market growth during the forecast period.

Request for Sample Copy of this Research Report:
https://www.accurizemarketresearch.com/report/colorectal-cancer-therapeutics-market/sample-request

North America is leading the highest market share and is further projected to climb the steepest rise owing to an increase in the cases of colorectal cancer, newer products launch, dense research and developments, awareness among the population, and well improved & advanced diagnostics for cancer prevention and its treatment.
The Asia Pacific is expected to garner the highest growth in the region owing to an increase in disposable incomes, improved healthcare facilities, and a huge population base during the forecast period.
Based on the therapy segment, targeted therapy is leading the global market owing to the presence of numerous targeted cancer therapies such as Stivarga, Erbitux, and Avastin in the market.
Prominent players inducing the Global Colorectal Cancer Therapeutics Market are Novartis AG, Genentech Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Sanofi, Taiho Pharmaceutical, Regeneron Pharmaceuticals Inc., Ipsen Biopharmaceuticals Inc., Eli Lily and Company, Bristol Myers Squibb, Merck Sharp & Dohme Corp., and Bayer AG among others.

Request for Customized report:
https://www.accurizemarketresearch.com/report/colorectal-cancer-therapeutics-market/ask-for-customization

Global Colorectal Cancer Therapeutics Market Segmentation:
By Therapy
• Immunotherapy
• Targeted Therapy
• Chemotherapy
• Others
By Cancer Type
• Gastrointestinal Carcinoid Tumors
• Colorectal Adenocarcinoma
• Others
By Diagnostics Techniques
• Colonoscopy
• Flexible Sigmoidoscopy
• Stool Tests
• Immunohistochemistry
• Other Diagnostics Techniques
By Distribution Channel
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
• Others
By Region
• North America
• Europe
• Asia Pacific
• Middle East & Africa
• Latin America

Contact:
Sana Tasneem
Head - Business Development
Patna Office (Asia):
K-129, PC Colony, Hanuman Nagar, Kankarbagh, Patna,
PIN - 800020
Tel: +1-339-368-6383/ +91-9665120699
Email: help@accurizemarketresearch.com
Web: https://www.accurizemarketresearch.com/
Accurize Market Research Blog:
https://www.accurizemarketresearch.com/blog-list

About Accurize Market Research-
Accurize Market Research (AMR) is a full-service market research and business-consulting company which provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Industry Intelligence Solutions”. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.” Destined by the dedicated team of analysts and experts, we are envisioned to provide you our best in order to plan your next strategic across several industry verticals.
We at Accurize Market Research provide syndicated as well as customized reports across domains namely Consumer Goods, Food & Beverages, Manufacturing, Medical Devices, Mining Equipment, Automation, Manufacturing, Healthcare & Medical, and Defense & Aerospace, Semiconductor & Electronics, Construction, Information and Communication, Construction, Banking, Financial Services and Insurance (BFSI), and Energy among others. These industry vertical areas are further studied and analyzed across different geographies namely North America, Europe, Asia Pacific, and the Rest of the World (RoW). The countries across these major geographies are also covered under the scope of our study; such as the U.S., Mexico, and Canada under North America; UK, Germany, Russia, Germany, and France among others under Europe. Similarly, China, India, Taiwan, South Korea, Australia, Singapore, and Japan among others are covered under the Asia Pacific. The Rest of the World (RoW) includes South & Central America, the Middle East, and Africa. Further, as per the scope countries across South & Central America, the Middle East and Africa would also be studied separately under the scope of the report.
Available Report Format: Excel/PDF/PPT/Word

This release was published on openPR.